Free Trial

FocalTherics (FOCL) 10K Form and Latest SEC Filings 2026

$4.52 -0.08 (-1.74%)
As of 06/9/2026 04:00 PM Eastern

Latest FocalTherics SEC Filings & Recent Activity

FocalTherics (NASDAQ:FOCL) has submitted 116+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 29, 2026.

Form 4
EDAP TMS SA Reports Ownership Change on May. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
FocalTherics Files Current Report on May. 29, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
FocalTherics Files Quarterly Report on May. 7, 2026

The 10-Q contains FocalTherics's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

FocalTherics SEC Filing History

Browse FocalTherics' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/29/2026 6:30 AM
FocalTherics (1041934) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2026 6:30 AM
FocalTherics (1041934) Filer
Form DEF 14A
05/14/2026 6:31 AM
FocalTherics (1041934) Filer
Form DEFA14A
05/14/2026 6:32 AM
FocalTherics (1041934) Filer
Form DEFA14A
05/14/2026 6:33 AM
FocalTherics (1041934) Filer
Form ARS
05/13/2026 5:03 AM
FocalTherics (1041934) Issuer
LEVINE JOSHUA (1159917) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:03 AM
FocalTherics (1041934) Issuer
Mobeck Kenneth S. (2104963) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:04 AM
FocalTherics (1041934) Issuer
WILLSEY LANCE (1202106) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:04 AM
FocalTherics (1041934) Issuer
Rhodes Ryan (1710383) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:05 AM
FocalTherics (1041934) Issuer
Shah Sanket (1986637) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:05 AM
Annen Steven (1672851) Reporting
FocalTherics (1041934) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2026 3:03 PM
FocalTherics (1041934) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 6:30 AM
FocalTherics (1041934) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2026 3:01 PM
FocalTherics (1041934) Filer
Form PRE 14A
03/31/2026 11:15 PM
FocalTherics (1041934) Filer
Form EFFECT
03/31/2026 3:55 PM
FocalTherics (1041934) Filer
Form 424B3
03/25/2026 3:15 PM
FocalTherics (1041934) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2026 3:25 PM
FocalTherics (1041934) Filer
Form S-3
Registration statement under Securities Act of 1933  
03/25/2026 6:30 AM
FocalTherics (1041934) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2026 6:30 AM
FocalTherics (1041934) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2026 4:59 PM
FocalTherics (1041934) Issuer
Horn David R. (1834217) Reporting
Form 3
Initial statement of beneficial ownership of securities  
02/12/2026 6:30 AM
FocalTherics (1041934) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2026 3:05 PM
FocalTherics (1041934) Issuer
WILLSEY LANCE (1202106) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/14/2026 3:05 PM
FocalTherics (1041934) Issuer
Rhodes Ryan (1710383) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/14/2026 3:05 PM
Annen Steven (1672851) Reporting
FocalTherics (1041934) Issuer
Form 3
Initial statement of beneficial ownership of securities  
01/13/2026 2:28 PM
Dietsch Francois Mattieu (2105026) Reporting
FocalTherics (1041934) Issuer
Form 3
Initial statement of beneficial ownership of securities  
01/13/2026 2:31 PM
FocalTherics (1041934) Issuer
Mobeck Kenneth S. (2104963) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/12/2026 6:30 AM
FocalTherics (1041934) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2026 7:06 PM
FocalTherics (1041934) Issuer
French Glendon E. III (1805624) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/09/2026 7:07 PM
FocalTherics (1041934) Issuer
Schulz Fran (2046804) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/09/2026 5:36 PM
FocalTherics (1041934) Issuer
Shah Sanket (1986637) Reporting
Form 3
Initial statement of beneficial ownership of securities  
01/09/2026 5:37 PM
FocalTherics (1041934) Issuer
LEVINE JOSHUA (1159917) Reporting
Form 3
Initial statement of beneficial ownership of securities  
11/20/2025 6:33 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2025 5:05 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2025 6:31 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/20/2025 8:25 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2025 4:04 PM
FocalTherics (1041934) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/09/2025 6:00 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2025 6:05 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2025 6:06 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2025 6:05 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
SpaceX billions need somewhere to go — this is it (Ad)

Washington is racing toward a July 4th deadline to sign the CLARITY Act into law... And Wall Street has been waiting for exactly this moment. For years, the biggest banks, asset managers, and trading firms have kept most of their serious capital on the crypto sidelines… not because they don't believe in it, but because there was no legal framework they could operate within. Our team has spent months identifying the one overlooked altcoin we believe is positioned to benefit more than anything else when that happens.tc pixel

07/01/2025 6:05 AM
FocalTherics (1041934) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

FocalTherics SEC Filings - Frequently Asked Questions

FocalTherics (FOCL) has submitted 116+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

FocalTherics's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 8-K submitted on May 29, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:FOCL) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners